BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29567426)

  • 1. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Geng L; Zhang T; Liu W; Chen Y
    Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
    Song Y; Liu Y; Chen X
    Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNHG1 promotes MPP
    Zhao J; Geng L; Chen Y; Wu C
    Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of BDNF production by MPP
    Zhang S; Chen S; Liu A; Wan J; Tang L; Zheng N; Xiong Y
    Neurosci Lett; 2018 May; 675():133-139. PubMed ID: 29030221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-124-3p attenuates MPP
    Geng L; Liu W; Chen Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1757-1764. PubMed ID: 28958159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
    Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
    Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhai K; Liu B; Gao L
    Hum Gene Ther; 2020 Dec; 31(23-24):1274-1287. PubMed ID: 32808542
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
    Wang Z; Sun L; Jia K; Wang H; Wang X
    Neurosci Lett; 2019 May; 701():226-233. PubMed ID: 30826419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-217/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP
    Wang M; Sun H; Yao Y; Tang X; Wu B
    Am J Transl Res; 2019; 11(10):6619-6631. PubMed ID: 31737212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA BACE1-antisense transcript plays a critical role in Parkinson's disease via microRNA-214-3p/Cell death-inducing p53-target protein 1 axis.
    Li L; Wang H; Li H; Lu X; Gao Y; Guo X
    Bioengineered; 2022 Apr; 13(4):10889-10901. PubMed ID: 35481549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
    Xu F; Bian N; Li X
    Neurochem Res; 2024 May; 49(5):1212-1225. PubMed ID: 38381247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA-p21 regulates MPP
    Ding XM; Zhao LJ; Qiao HY; Wu SL; Wang XH
    Chem Biol Interact; 2019 Jul; 307():73-81. PubMed ID: 31004593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis.
    Zhang L; Wang J; Liu Q; Xiao Z; Dai Q
    Neurotoxicology; 2020 May; 78():29-35. PubMed ID: 32057949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-103a-3p regulates mitophagy in Parkinson's disease through Parkin/Ambra1 signaling.
    Zhou J; Zhao Y; Li Z; Zhu M; Wang Z; Li Y; Xu T; Feng D; Zhang S; Tang F; Yao J
    Pharmacol Res; 2020 Oct; 160():105197. PubMed ID: 32942015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
    Ren Y; Ye D; Ding Y; Wei N
    Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
    Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
    Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease.
    Chen MY; Fan K; Zhao LJ; Wei JM; Gao JX; Li ZF
    Bioengineered; 2021 Dec; 12(1):708-719. PubMed ID: 33522352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SRY-box transcription factor 2 overlapping transcript participates in Parkinson's disease by regulating the microRNA-942-5p/nuclear apoptosis-inducing factor 1 axis.
    Guo Y; Liu Y; Wang H; Liu P
    Bioengineered; 2021 Dec; 12(1):8570-8582. PubMed ID: 34607512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease.
    Zheng Y; Dong L; Liu N; Luo X; He Z
    Biomed Res Int; 2020; 2020():7239895. PubMed ID: 33204711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.